Short talks Pharmacology 13
CNS / endocrine pharmacology and treatment

Programme

• 17:30 – 17:45 10 Min. 5 Min.

  • Oral presentation
  • 60

  The influence of the AT1-receptor blocker Telmisartan on endothelial function in AAV-PCSK9^DY atherosclerosis mice is dependent on the ACE2/Ang(1-7)/Mas axis

  • Walter Raasch (Lübeck / DE)

   CNS / endocrine pharmacology, Disease models, drug development
• 17:45 – 18:00 10 Min. 5 Min.

  • Oral presentation
  • 61

  Cognitive function and cerebral blood flow are impaired in AAV-PCSK9^DY atherosclerotic mice

  • Walter Raasch (Lübeck / DE)

   CNS / endocrine pharmacology, Disease models, drug development
• 18:00 – 18:15 10 Min. 5 Min.

  • Oral presentation
  • 62

  The role of VDAC1 inhibitor Akos-22 in ferroptotic cell death

  • Stephan Tang (Marburg / DE)

   CNS / endocrine pharmacology, Immunopharmacology / inflammation / anti-infectives
• 18:15 – 18:30 10 Min. 5 Min.

  • Oral presentation
  • 63

  Dissecting molecular mechanisms of beta cell dysfunction in type 2 diabetes using single cell multiomics

  • Sebastian Preissl (Freiburg / DE)

   CNS / endocrine pharmacology, Pharmacogenomics and personalized medicine